Kidney Disease Clinical Trials in New York

Showing 261-280 of 478 trials

Evolocumab In Advanced Chronic Kidney Disease Trial

NCT04510844

110 individuals with stage 4-5 Chronic Kidney Disease (CKD) will be randomized to 1-year of blinded Evolocumab or placebo. Subjects will undergo evaluation of circulating lipids at baseline and end of study. A substudy including 50 subjects will assess myocardial rest and stress positron emission tomography (PET) at baseline and at 1-year.

Chronic Kidney DiseasesHigh Cholesterol

NYU Langone HealthStarted Mar 2021

Mineola, New York, United States • New York, New York, United States

COMPLETEDPhase 1/2< 1 mile

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

NCT01034631

The purpose of this study is to determine whether BNC105P in combination with/following everolimus is effective in the treatment of progressive metastatic clear cell renal cell carcinoma following prior tyrosine kinase inhibitors.

Renal Cell Carcinoma

Hoosier Cancer Research Network154 participantsStarted Jan 2010

Muscle Shoals, Alabama, United States • Hot Springs, Arkansas, United States • Burbank, California, United States +105 more locations

Evolocumab In Advanced Chronic Kidney Disease Trial

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Kidney Disease Trials in Other Cities

Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD

Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease

Kidney Precision Medicine Project

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

Improving Outcomes for Hemodialysis Patients

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis

Effect of Lost Wage Reimbursement to Kidney Donors on Living Donation Rates

Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.

42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer

Safety Study of MGA271 in Refractory Cancer

Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101

Decision Aid for Renal Therapy

Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

Other Conditions in New York